jump to: 2006-2000 1999-1995 1994-1978
2006
1. Hasan CU, Menon LG, Kim SK, Ramakrishna N, Bello L, Black PM, Carroll RS. Continuous intracranial administration of suberoylanilidehydroxamic acid (SAHA) inhibits tumor growth in an orthotopic glioma model. Submitted J Neuro, 2006.
2. El-Ouahabi A, Black PM, Loeffler JS, Wen PY. Malignant Gliomas in Adults: The Importance of Aggressive Treatment. Pan Arab J Neuro. In press, 2006.
2004
3. Robe PA, Bentires-Alj M, Bonif M, Rogister B, Deprez M, Haddada H, Khac MT, Jolois O, Erkemn K, Merville MP, Black PM, Bours V. In Vitro and In Vivo Activity of the NF-kappaB Inhibitor Sulfasalazine in Human Glioblastomas . Clin Cancer Res, 10(16): 5595-5603, 2004.
4. Chakravarti A, Zhai G, Suzuki Y, Sarkesh S, Black PM, Muzikansky A, Loeffler JS. The prognostic significance of Phosphatidylinositol 3-kinase pathway activation in human gliomas . J Clin Oncol, 22(10)1926-1933, 2004.
2003
5. Dunn IF, Black PM. The Neurosurgeon as Local Oncologist: Cellular and molecular neurosurgery in malignant glioma therapy . Neurosurgery, 52(6): 1422-1424, 2003.
6. Bello L, Lucini V, Guissani C, Carrabba G, Pluderi M, Scaglione F, Tomei G, Vilanni R, Black PM, Bikfalvi A, Carroll RS. IS201, A Specific alphavbeta3 Integrin Inhibitor, Reduces Glioma Growth in Vivo . Neurosurgery, 52(1): 177-185, 2003.
7. Nutt CL, Mani DR, Betensky RA, Tamayo P, Cairncross JG, Ladd C, Pohl U, Hartman C, McLaughlin ME, Batchelor TT, Black PM, von Deimling A, Pomeroy SL, Golub TR, Louis DN. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification . Cancer Res, 63(7): 1602-1607, 2003.
2002
8. Chakravarti A, Noll E, Black PM, Finkelstein DF, Dyson NJ, Loeffler JS. Quantitatively determined survivin expression levels are of prognostic value in human gliomas . J Clin Oncol, 20(4): 1063-1068, 2002.
2001
9. Kirsch M, Santarius T, Black PM, Schackert G. Therapeutic anti-angiogenesis for malignant brain tumors . Onkologie, 24(5): 423-430, 2001.
10. Chakravarti A, Delaney MA, Noll E, Black PM, Loeffler JS, Muzikansky, Dyson NJ. Prognostic and pathologic significance of protein expression profiling in human gliomas . Clin Cancer Res, 7(8): 2387-2395, 2001.
11. Noll E, Lin J, Nakatsuji Y, Miller RH, Black PM. GM3 as a Novel Growth Regulator for Human Gliomas . Exp Neurol, 168(2): 300-309, 2001.
12. Bello L, Francolini M, Marthyn P, Zhang J, Carroll RS, Nikas DC, Strasser JF, Villani R, Cheresh DA, Black PM. Alpha(v)beta3 and alpha(v)beta5 Integrin Expression in Glioma Periphery . Neurosurgery, 49(2): 380-389, 2001.
2000
13. Dunn IF, Heese O, Black PM. Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs . J Neurooncol, 50(1-2): 121-137, 2000.
14. Zhou XP, Smith WM, Gimm O, Mueller E, Gao X, Sarraf P, Prior TW, Plass C, von Deimling A, Black PM, Yates AJ, Eng C. Over-representation of PPARgamma Sequence Variants in Sporadic Cases of Glioblastoma Multiforme: preliminary evidence for common low penetrance modifiers for brain tumour risk in the general population . J Med Genet, 37(6): 410-414, 2000.
15. Kilic T, Alberta JA, Zdunek PR, Acar M, Iannarelli P, O'Reilly T, Buchdunger E, Black PM, Stiles CD. Intracranial Inhibition of Platelet-derived Growth Factor-mediated Glioblastoma Cell Growth by an Orally Active Kinase Inhibitor of the 2-phenylaminopyrimidine Class . Cancer Res, 60(18): 5143-5150, 2000.
16. Chattopadhyay N, Singh DP, Heese O, Godbole M, Sinohara T, Black PM, Brown EM. Expression of Peroxisome Proliferator-Activated Receptors (PPARs) in Human Astrocytic Cells: PPARgamma Agonists as Inducers of Apoptosis . J Neurosci Res, 61(1): 67-74, 2000.
17. Evliyaoglu C, Carroll R, Folkerth R, Bello L, Bruns DE , Black PM. Parathyroid Hormone-related Protein and Its Receptor in Human Glial Tumors . Acta Neurochir (Wein), 142(8): 871-878, 2000.
18. Park CC, Hartmann C, Folkerth R, Loeffler JS, Wen PY, Fine HA, Black PM, Shafman T, Louis DN. Systemic Metastasis in Glioblastoma May Represent the Emergence of Neoplastic Subclones . J Neuropathol Exper Neurol 59(12): 1044-1050, 2000.
19. Joki T, Heese O, Nikas D, Bello L, Zhang J, Kraeft S, Seyfried N, Abe T, Chen L, Carroll R, Black P. Expression of Cyclooxygenase-2 (COX-2) in Human Glioma and in vitro Inhibition by a Specific COX-2 Inhibitor, NS-398 . Cancer Res, 60(17): 4926-4931, 2000.
20. Zhou XP, Smith WM, Gimm O, Mueller E, Gao X, Sarraf P, Prior TW, Plass C, von Deimling A, Black PM, Yates AJ, Eng C. Over-representation of PPARgamma Sequence Variants in Sporadic Cases of Glioblastoma Multiforme: preliminary evidence for common low penetrance modifiers for brain tumour risk in the general population . J Med Genet, 37(6): 410-414, 2000.
21. Bouterfa H, Picht T, Kess D, Herbold C, Noll E, Black PM, Roosen K, Tonn JC. Retinoids inhibit human glioma cell proliferation and migration in primary cell cultures but not in established cell lines . Neurosurgery, 46(2): 419-430, 2000.
1999
22. Carroll R, Zhang J, Bello L, Melnick M, Maruyama T, Comb M, Black PM, KDR Activation in Human Astrocytic Neoplasms. Cancer, 86(7): 1335-1341, 1999.
1998
23. Di Rocco F, Carroll RS, Zhang J, Black PM. Platelet-derived Growth Factor and its Receptor Expression in Human Oligodendrogliomas . Neurosurgery, 42(2): 341-346, 1998.
24. Noll E, Black PM. Retention of an appropriate astrocytic response to retinoids by human brain tumors composed of predominantly glial fibrillary acidic protein-positice cells. Neurosurg Focus 4 (4): Article 2, 1998.
1997
25. Kirsch M, Wilson JC, Black P. Platelet-derived growth factor in human brain tumors. J Neurooncol, 35(3): 289-301, 1997.
26. Imitola J, Nikas D, Black PM. Apoptosis in tumors of the central nervous system. Crit Rev Neurosurg 1997; 7: 391-399.
27. Shamah SM, Alberta JA, Giannobile WV , Guha A, Kwon YK , Carroll RS, Black PM, Stiles CD. Detection of Activated Platelet-derived Growth Factor Receptors in Human Meningioma . Cancer Research, 57(18): 4141-4147, 1997.
28. Carroll RS, Black PM, Zhang J, Kirsch M, Percec I, Lau N, Guha A. Expression and activation of epidermal growth factor receptors in meningiomas . J Neurosurg, 87(2): 315-323, 1997.
1996
29. Black PM, Carroll R, Zhang J. The Molecular Biology of Hormone and Growth Factor Receptors on Meningiomas. Acta Neurochir Suppl, 65: 50-53, 1996.
30. Kalkanis SN, Carroll RS, Zhang JP, Zamani AA, Black PM. Correlation of Vascular Endothelial Growth Factor Messenger RNA Expression with Peritumoral Vasogenic Cerebral Edema in Meningiomas . J Neurosurg, 85(6): 1095-1101, 1996.
31. Black PM, Carroll R, Glowacka D. The Expression of Platelet-Derived Growth Factor Transcripts in Medulloblastomas and Ependymomas. Pediatr Neurosurg., 24(2): 74-78, 1996.
1995
32. Guha A, Glowacka D, Carroll R, Dashner K, Black PM, Stiles CD. Expression of Platelet Derived Growth Factor and Platelet Derived Growth Factor Receptor mRNA in a Glioblastoma from a Patient with Li-Fraumeni Syndrome . J Neurol Neurosurg Psychiatry, 58(6): 711-714, 1995.
33. Carroll RS, Zhang J, Dashner K, Sar M, Black PM. Steroid hormone receptor in astrocytic neoplasms . Neurosurgery, 37(3): 496-503, 1995.
34. Guha A, Dashner K, Black PM, Wagner JA, Stiles CD. Expression of PDGF and PDGF Receptors in Human Astrocytoma Operation Specimens Supports the Existence of an Autocrine Loop . Int J Cancer, 60(2):168-173, 1995.
1994
35. Busque L, Zhu J, DeHart D, Griffith B, Willman C, Carroll R, Black PM, Gilliland DG. An Expression Based Clonality Assay at the Human Androgen Receptor Locus (HUMARA) on Chromosome X . Nucleic Acids Res, 22(4): 697-698, 1994.
36. Black PM, Carroll R, Glowacka D, Riley K, Dashner K. Platelet-derived Growth Factor Expression and Stimulation in Human Meningiomas . J Neurosurg, 81(3): 388-393, 1994.
1990
37. Maxwell M, Galanopoulos T, Hedley-Whyte ET, Black PM, Antoniades HN. Human meningiomas co-express platelet-derived growth factor (PDGF) and PDGF-receptor genes and their protein products . Int J Cancer 46(1):16-21, 1990.
38. Maxwell M, Naber SP, Wolfe HJ, Galanopoulos T, Hedley-Whyte ET, Black PM, Antoniades HN. Coexpression of platelet-derived growth factor (PDGF) and PDGF-receptor genes by primary human astrocytomas may contribute to their development and maintenance . J Clin Invest, 86(1):131-40, 1990.
39. Hsu DW, el-Azouzi M, Black PM, Chin WW, Hedley-Whyte ET, Kaplan LM. Estrogen increases galanin immunoreactivity in hyperplastic prolactin-secreting cells in Fisher 344 rats . Endocrinology, 126(6): 3159-3167, 1990.
1980
40. Black PM, Kornblith PL. Biophysical properties of human astrocytic brain tumor cells in cell culture . J Cell Physiol., 105(3): 565-570, 1980.
1978
41. Black PM, Callahan LV , Kornblith PL. Tissue cultures from cerebrospinal fluid specimens in the study of human brain tumors . J Neurosurg, 49(5): 697-704, 1978.
designed by symposi.com